Several organizations offer events specifically geared towards and about metastatic breast cancer. This is not a comprehensive listing, and you may find additional events in your local community. Please feel free to share/comment below with other resources or organizations that may have provided you support and may benefit the broader community. In addition, some hospitals, comprehensive cancer centers, and research institutions may also offer events focused on metastatic breast cancer.
Living Beyond Breast Cancer
Living Beyond Breast Cancer (LBBC) provides programs and support for those impacted by breast cancer. For more than a decade, they have sponsored an annual conference on metastatic breast cancer. Details can be found on their website. They also offer webinars and fundraising events.
Metastatic Breast Cancer Alliance
Metastatic Breast Cancer Alliance (MBCA) is a coalition of charity, advocacy, and pharmaceutical organizations. MBCA sponsors an annual medical conference on metastatic breast cancer. It has high-level scientific content and is geared towards healthcare professionals. However, they do offer a limited program for advocates.
Metastatic Breast Cancer Network
Metastatic Breast Cancer Network (MBCN) is a patient advocacy group for the unique concerns of women and men living with metastatic breast cancer. MBCN has co-sponsored a metastatic breast cancer conference and has created a database of events from various organizations on their website.
METAvivor is dedicated to women and men living with metastatic breast cancer. While they are focused on raising funds and giving grants for research into metastatic breast cancer, they do organize local fundraising events that are searchable online.
Susan G. Komen
Susan G. Komen is an organization that funds research, community outreach, and education on breast cancer. Komen organizes a metastatic breast cancer conference, and local events have included a dinner series featuring experts from research and clinical organizations.
Written by: Emily Downward | Last reviewed: December 2018.